These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


387 related items for PubMed ID: 30424815

  • 1. A CpG oligodeoxynucleotide enhances the immune response to rabies vaccination in mice.
    Yu P, Yan J, Wu W, Tao X, Lu X, Liu S, Zhu W.
    Virol J; 2018 Nov 13; 15(1):174. PubMed ID: 30424815
    [Abstract] [Full Text] [Related]

  • 2. A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine.
    Wang X, Bao M, Wan M, Wei H, Wang L, Yu H, Zhang X, Yu Y, Wang L.
    Vaccine; 2008 Mar 28; 26(15):1893-901. PubMed ID: 18321616
    [Abstract] [Full Text] [Related]

  • 3. A novel canine favored CpG oligodeoxynucleotide capable of enhancing the efficacy of an inactivated aluminum-adjuvanted rabies vaccine of dog use.
    Ren J, Sun L, Yang L, Wang H, Wan M, Zhang P, Yu H, Guo Y, Yu Y, Wang L.
    Vaccine; 2010 Mar 11; 28(12):2458-64. PubMed ID: 20067754
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial.
    Pineda-Peña AC, Jiang Q, Petit C, Korejwo-Peyramond J, Donazzolo Y, Latreille M, Homery MC, Babin V, Benamor S, Pichon S, Guinet-Morlot F, Minutello AM.
    Clin Infect Dis; 2024 Jun 14; 78(6):1748-1756. PubMed ID: 38478634
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of a new chromatographically purified rabies vaccine in comparison to the human diploid cell vaccine.
    Arora A, Moeller L, Froeschle J.
    J Travel Med; 2004 Jun 14; 11(4):195-9. PubMed ID: 15541220
    [Abstract] [Full Text] [Related]

  • 8. Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults.
    Pichon S, Moureau A, Petit C, Kirstein JL, Sheldon E, Guinet-Morlot F, Minutello AM.
    Vaccine; 2024 Apr 11; 42(10):2553-2559. PubMed ID: 38105138
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries.
    Bernard KW, Fishbein DB, Miller KD, Parker RA, Waterman S, Sumner JW, Reid FL, Johnson BK, Rollins AJ, Oster CN.
    Am J Trop Med Hyg; 1985 May 11; 34(3):633-47. PubMed ID: 4003672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
    Singh SM, Alkie TN, Abdelaziz KT, Hodgins DC, Novy A, Nagy É, Sharif S.
    Viral Immunol; 2016 Jun 11; 29(5):269-75. PubMed ID: 27077969
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers.
    Wijaya L, Tham CYL, Chan YFZ, Wong AWL, Li LT, Wang LF, Bertoletti A, Low JG.
    Vaccine; 2017 Feb 22; 35(8):1175-1183. PubMed ID: 28118938
    [Abstract] [Full Text] [Related]

  • 20. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M, Saxena A, Rai A, Bhatnagar R.
    FASEB J; 2010 Jan 22; 24(1):173-83. PubMed ID: 19741168
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.